Overweight or Obesity Clinical Trials in Baltimore, Maryland
3 recruitingBaltimore, Maryland
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
HypertensionOverweight or Obesity
Eli Lilly and Company487 enrolled99 locationsNCT06948435
Recruiting
Not Applicable
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
Peripheral Artery DiseaseOverweight or Obesity
Northwestern University212 enrolled7 locationsNCT04228978
Recruiting
Phase 1
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
HealhtyOverweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd.60 enrolled1 locationNCT07224399